MAM
COLL icon

Meeder Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Meeder Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9
Closed – – 1032
2022
Q3 		$0 Buy
+9
New +$159 ﹤0.01% 2174
2022
Q2 		– Sell
-17
Closed – – 2208
2022
Q1 		$0 Buy
+17
New +$321 ﹤0.01% 2346
2020
Q4 		– Sell
-396
Closed -$8K – 1940
2020
Q3 		$8K Sell
396
-2,331
-85% -$42.1K ﹤0.01% 1429
2020
Q2 		$47K Sell
2,727
-635
-19% -$12.4K ﹤0.01% 930
2020
Q1 		$54K Sell
3,362
-744
-18% -$15.4K ﹤0.01% 884
2019
Q4 		$85K Sell
4,106
-4,389
-52% -$73.2K 0.01% 844
2019
Q3 		$97K Buy
8,495
+7,888
+1,300% +$90.1K 0.01% 811
2019
Q2 		$8K Sell
607
-1,711
-74% -$22.9K ﹤0.01% 1516
2019
Q1 		$34K Sell
2,318
-1,354
-37% -$21.7K ﹤0.01% 953
2018
Q4 		$62K Buy
3,672
+3,179
+645% +$54.4K 0.01% 757
2018
Q3 		$7K Sell
493
-2,888
-85% -$51.2K ﹤0.01% 1240
2018
Q2 		$80.6K Buy
3,381
+3,329
+6,402% +$81.9K 0.01% 662
2018
Q1 		$1K Buy
52
+2
+4% +$48 ﹤0.01% 1444
2017
Q4 		$1K Buy
+50
New +$716 ﹤0.01% 1557
2017
Q2 		– Sell
-902
Closed -$10K – 1690
2017
Q1 		$10K Buy
902
+454
+101% +$6.75K ﹤0.01% 857
2016
Q4 		$7K Buy
+448
New +$7.45K ﹤0.01% 808

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Meeder Asset Management's COLL Position: Q4 2022 in Review

Meeder Asset Management sold out of Collegium Pharmaceutical (COLL) in Q4 2022, closing a stake of 9 shares.

Meeder Asset Management first reported a position in COLL in Q4 2016 and held it in 16 quarters. The position peaked at $97K in Q3 2019. 179 funds tracked by Wall St. Rank hold COLL as of Q4 2022.

  • Meeder Asset Management reported no remaining Collegium Pharmaceutical position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 9 Collegium Pharmaceutical shares in Q4 2022.
  • Meeder Asset Management first reported a position in Collegium Pharmaceutical in Q4 2016 and held it in 16 quarters.
  • Meeder Asset Management's Collegium Pharmaceutical position peaked at $97K in Q3 2019.
  • 179 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.